279 related articles for article (PubMed ID: 34721017)
1. Mechanisms Underlying the Effects of Lianhua Qingwen on Sepsis-Induced Acute Lung Injury: A Network Pharmacology Approach.
Yang R; Yang H; Wei J; Li W; Yue F; Song Y; He X; Hu K
Front Pharmacol; 2021; 12():717652. PubMed ID: 34721017
[No Abstract] [Full Text] [Related]
2. Lianhua Qingwen protects LPS-induced acute lung injury by promoting M2 macrophage infiltration.
Li S; Feng T; Zhang Y; Shi Q; Wang W; Ren J; Shen G; Gu H; Luo C; Li Y
J Ethnopharmacol; 2024 Feb; 320():117467. PubMed ID: 37981112
[TBL] [Abstract][Full Text] [Related]
3. Uncovering the active constituents and mechanisms of Rujin Jiedu powder for ameliorating LPS-induced acute lung injury using network pharmacology and experimental investigations.
Ma Y; Xu H; Chen G; Liu W; Ma C; Meng J; Yuan L; Hua X; Ge G; Lei M
Front Pharmacol; 2023; 14():1186699. PubMed ID: 37251341
[No Abstract] [Full Text] [Related]
4. Intestinal microbiota analysis and network pharmacology reveal the mechanism by which Lianhua Qingwen capsule improves the immune function of mice infected with influenza A virus.
Xu P; Yang Z; Du S; Hong Z; Zhong S
Front Microbiol; 2022; 13():1035941. PubMed ID: 36504796
[TBL] [Abstract][Full Text] [Related]
5. Lianhua Qingwen exerts anti-liver cancer effects and synergistic efficacy with sorafenib through PI3K/AKT pathway: Integrating network pharmacology, molecular docking, and experimental validation.
Wei J; Zhao X; Long F; Tian K; Wu L
Gene; 2024 Jun; 912():148383. PubMed ID: 38493972
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of Wenqingyin on sepsis-induced acute lung injury through regulation of the receptor for advanced glycation end products pathway.
Xie L; Zhang G; Wu Y; Hua Y; Ding W; Han X; Liu B; Zhou C; Li A
Phytomedicine; 2024 Jul; 129():155654. PubMed ID: 38723525
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy and mechanism of Lianhua Qingwen Capsules(LHQW) on chemotaxis of macrophages in acute lung injury (ALI) animal model].
Li Q; Yin J; Ran QS; Yang Q; Liu L; Zhao Z; Li YJ; Chen Y; Sun LD; Wang YJ; Weng XG; Cai WY; Zhu XX
Zhongguo Zhong Yao Za Zhi; 2019 Jun; 44(11):2317-2323. PubMed ID: 31359658
[TBL] [Abstract][Full Text] [Related]
8. Molecular mechanism of honeysuckle + forsythia in treatment of acute lung injury based on network pharmacology.
Wen X; Cheng M; Song Z; Hu J; Liang X; Lang W; Yang M; Zhou R; Hao Y
Biomed Rep; 2024 Feb; 20(2):32. PubMed ID: 38273899
[TBL] [Abstract][Full Text] [Related]
9. Predicting for anti-(mutant) SARS-CoV-2 and anti-inflammation compounds of Lianhua Qingwen Capsules in treating COVID-19.
Hong L; He M; Li S; Zhao J
Chin Med; 2022 Jul; 17(1):84. PubMed ID: 35799189
[TBL] [Abstract][Full Text] [Related]
10. Systems pharmacology reveals the mechanism of activity of Ge-Gen-Qin-Lian decoction against LPS-induced acute lung injury: A novel strategy for exploring active components and effective mechanism of TCM formulae.
Ding Z; Zhong R; Yang Y; Xia T; Wang W; Wang Y; Xing N; Luo Y; Li S; Shang L; Shu Z
Pharmacol Res; 2020 Jun; 156():104759. PubMed ID: 32200026
[TBL] [Abstract][Full Text] [Related]
11. Molecular docking and molecular dynamics study Lianhua Qingwen granules (LHQW) treats COVID-19 by inhibiting inflammatory response and regulating cell survival.
Cao JF; Gong Y; Wu M; Xiong L; Chen S; Huang H; Zhou X; Peng YC; Shen XF; Qu J; Wang YL; Zhang X
Front Cell Infect Microbiol; 2022; 12():1044770. PubMed ID: 36506032
[TBL] [Abstract][Full Text] [Related]
12. Network pharmacology and computer-aided drug design to explored potential targets of Lianhua Qingwen and Qingfei Paidu decoction for COVID-19.
Li L; Wang X; Guo X; Li Y; Song Q; Li A
Front Pharmacol; 2022; 13():1013428. PubMed ID: 36210820
[TBL] [Abstract][Full Text] [Related]
13. Lipopolysaccharide-Induced Acute Lung Injury Is Associated with Increased Ran-Binding Protein in Microtubule-Organizing Center (RanBPM) Molecule Expression and Mitochondria-Mediated Apoptosis Signaling Pathway in a Mouse Model.
Lv X; Lu X; Zhu J; Wang Q
Med Sci Monit; 2020 Jul; 26():e923172. PubMed ID: 32680981
[TBL] [Abstract][Full Text] [Related]
14. Exploration of the Mechanism of Lianhua Qingwen in Treating Influenza Virus Pneumonia and New Coronavirus Pneumonia with the Concept of "Different Diseases with the Same Treatment" Based on Network Pharmacology.
Su H; Wu G; Zhan L; Xu F; Qian H; Li Y; Zhu X
Evid Based Complement Alternat Med; 2022; 2022():5536266. PubMed ID: 35145559
[TBL] [Abstract][Full Text] [Related]
15. Lianhuaqingwen alleviates p53-mediated apoptosis in alveolar epithelial cells to prevent LPS-induced ALI.
Yang R; Yang H; Li W; Yue F; Chen H; Hao Y; Hu K
J Pharm Pharmacol; 2022 Aug; 74(8):1117-1124. PubMed ID: 35640566
[TBL] [Abstract][Full Text] [Related]
16. Establishment of an anti-inflammation-based bioassay for the quality control of the 13-component TCM formula (Lianhua Qingwen).
Chen S; Yang X; Wei Z; Zhang Y; Huang Y; Shi Z; Zhang Z; Wang J; Zhang H; Ma J; Xiao X; Niu M
Pharm Biol; 2021 Dec; 59(1):537-545. PubMed ID: 33941036
[TBL] [Abstract][Full Text] [Related]
17. Integrating UPLC-Q-Orbitrap MS with serum pharmacochemistry network and experimental verification to explore the pharmacological mechanisms of
Gao H; Yuan Z; Liang H; Liu Y
Front Pharmacol; 2024; 15():1261772. PubMed ID: 38584603
[No Abstract] [Full Text] [Related]
18. Network pharmacology and molecular docking analyses on Lianhua Qingwen capsule indicate Akt1 is a potential target to treat and prevent COVID-19.
Xia QD; Xun Y; Lu JL; Lu YC; Yang YY; Zhou P; Hu J; Li C; Wang SG
Cell Prolif; 2020 Dec; 53(12):e12949. PubMed ID: 33140889
[TBL] [Abstract][Full Text] [Related]
19. Lianhua Qingwen prescription for Coronavirus disease 2019 (COVID-19) treatment: Advances and prospects.
Li LC; Zhang ZH; Zhou WC; Chen J; Jin HQ; Fang HM; Chen Q; Jin YC; Qu J; Kan LD
Biomed Pharmacother; 2020 Oct; 130():110641. PubMed ID: 34321172
[TBL] [Abstract][Full Text] [Related]
20. An integrated network pharmacology and RNA-Seq approach for exploring the preventive effect of Lonicerae japonicae flos on LPS-induced acute lung injury.
Liu C; Yin Z; Feng T; Zhang M; Zhou Z; Zhou Y
J Ethnopharmacol; 2021 Jan; 264():113364. PubMed ID: 32916233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
